Product Review – Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma
Haematology Watch 34 – T-cell clones of uncertain significance
Lymphoma & Leukaemia Research Review, Issue 93
CAR-T Cell Therapy Research Review, Issue 4
Haematology Research Review, Issue 137
Haematology Practice Review Issue 57
Study Review – The ECHELON-1 trial – Hodgkin Lymphoma
Professor Michael Dickinson discusses CAR T-Cell Therapy: Axicabtagene Ciloleucel for Second-Line Treatment of Relapsed or Refractory Large B-Cell Lymphoma
https://vimeo.com/1073445619https://vimeo.com/1073446157https://vimeo.com/1073446868https://vimeo.com/1073447292
Lymphoma & Leukaemia Watch 41 – Novel approaches in T cell lymphoma
